High Purity Heparin Sodium Powder CAS 9041-08-1

• Customization: Available
• Powder: Yes
• Customized: Customized
• Model NO.: TGY201906090703
• Certification: GMP, ISO 9001, USP, BP
• Suitable for: Elderly, Adult
• State: Powder
• Purity: >98%
• Product Name: Heparin Sodium
• Appearance: White Powder
• CAS No.: 9041-08-1
• Molecular Formula: (C12h16ns2na3)20
• Molecular Weight: 359.66
• Assay: 99%
• Coa: Available
• Sample: Available
• MOQ: Any Quantitiy
• Service: OEM
• Grade: Pharmaceutical Grade
• Test Method: USP;GMP
• Storage: Cool Dry Area
• Shelf Life: 24 Months Properly
• Certificate: ISO9001:2008
• Transport Package: Boil Bag
• Specification: HPLC 99%
• Trademark: TGY
• Origin: Xi′an, Shaanxi, China (Mainland)
• HS Code: 29225090
• Production Capacity: 5000kg/Month

Product Description

n

Common Name	Heparin sodium salt
CAS Number	9041-08-1
Molecular Weight	6117(Average)
Molecular Formula	(C14H25NO20S3)n.xNa

Heparin sodium salt, used as an anticoagulant, is a mucopolysaccharide substance, is the sodium salt form of glucosamine sulfate extracted from the intestinal mucosa of pigs, cattle, and sheep. It is secreted by mast cells to be naturally presented the blood inside the human bodies. Heparin can prevent platelet aggregation and destruction, inhibit the conversion from fibrinogen to fibrin monomers, inhibit the formation of thromboplastin and fight against the pre-formed thromboplastin, and also prevent the conversion of prothrombin to thrombin and counteract the antithrombin

1.The treatment of various diseases concurrent disseminated intravascular coagulation early. 
2.Prevention of arterial and venous thrombosis and pulmonary embolism.
3.Treatment of arterial and venous thrombosis and pulmonary embolism, ischemic stroke, unstable angina (to alleviate the symptoms, prevention of myocardial infarction), acute myocardial infarction (prevention of early reinfarction and infarct extension, reduce mortality). 
4.The artificial lung, peritoneal dialysis or hemodialysis as anticoagulants.
5.thrombolytic therapy as maintenance therapy. 
6.used for the prevention of blood coagulation and blood bank transfusion of blood and other body save anticoagulants.